241 related articles for article (PubMed ID: 9988141)
1. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
2. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases.
Favero M; Calò LA; Schiavon F; Punzi L
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744
[TBL] [Abstract][Full Text] [Related]
3. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
[TBL] [Abstract][Full Text] [Related]
4. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
[TBL] [Abstract][Full Text] [Related]
5. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
[TBL] [Abstract][Full Text] [Related]
6. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
[TBL] [Abstract][Full Text] [Related]
7. [Bartter's syndrome: new classification, old therapy].
Peco-Antic A; Dudic S; Marsenic O; Zivic G
Srp Arh Celok Lek; 2001; 129(5-6):139-42. PubMed ID: 11797462
[TBL] [Abstract][Full Text] [Related]
8. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
9. Bartter's and Gitelman's syndromes: from gene to clinic.
Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
Koulouridis E; Koulouridis I
World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
[TBL] [Abstract][Full Text] [Related]
11. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.
Simon DB; Karet FE; Hamdan JM; DiPietro A; Sanjad SA; Lifton RP
Nat Genet; 1996 Jun; 13(2):183-8. PubMed ID: 8640224
[TBL] [Abstract][Full Text] [Related]
12. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.
Simon DB; Nelson-Williams C; Bia MJ; Ellison D; Karet FE; Molina AM; Vaara I; Iwata F; Cushner HM; Koolen M; Gainza FJ; Gitleman HJ; Lifton RP
Nat Genet; 1996 Jan; 12(1):24-30. PubMed ID: 8528245
[TBL] [Abstract][Full Text] [Related]
13. Constitutive nitric oxide synthase gene expression in Bartter's and Gitelman's syndrome and its relationship to their vascular hyporesponsiveness.
Calò L; Bordin MC; Davis PA; Cantaro S; Milani M; Gandolfi L; Favaro S; Antonello A; Fagiolo U; D'Angelo A
Contrib Nephrol; 1997; 122():193-5. PubMed ID: 9399065
[No Abstract] [Full Text] [Related]
14. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
Peters N; Bettinelli A; Spicher I; Basilico E; Metta MG; Bianchetti MG
Nephrol Dial Transplant; 1995; 10(8):1313-9. PubMed ID: 8538920
[TBL] [Abstract][Full Text] [Related]
17. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
[TBL] [Abstract][Full Text] [Related]
18. Hypokalemic metabolic alkalosis--three case reports.
Galesić K; Bozić B; Sćukanec-Spoljar M; Morović-Vergles J; Cvitković-Kuzmić A; Ljubanović D
Acta Med Croatica; 2001; 55(4-5):219-23. PubMed ID: 12398028
[TBL] [Abstract][Full Text] [Related]
19. Problems in diagnosing atypical Gitelman's syndrome presenting with normomagnesaemia.
Nakamura A; Shimizu C; Nagai S; Yoshida M; Aoki K; Kondo T; Miyoshi H; Wada N; Tajima T; Terauchi Y; Yoshioka N; Koike T
Clin Endocrinol (Oxf); 2010 Feb; 72(2):272-6. PubMed ID: 19508680
[TBL] [Abstract][Full Text] [Related]
20. [Renal sodium transport abnormality: Gitelman's syndrome and renal sodium transporter].
Takeuchi K; Taniyama Y; Ito S; Yasujima M
Rinsho Byori; 1999 Dec; 47(12):1128-33. PubMed ID: 10639822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
